Gena L. Ashe - 17 May 2022 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Chief Legal Officer & Corp Sec
Signature
/s/ Gena Ashe, Attorney-in-Fact
Issuer symbol
ATEX
Transactions as of
17 May 2022
Net transactions value
$0
Form type
4
Filing time
19 May 2022, 16:15:56 UTC
Previous filing
02 Mar 2022
Next filing
01 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATEX Common Stock Award $0 +9,112 +27% $0.000000 42,811 17 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +18,368 $0.000000 18,368 17 May 2022 Common Stock 18,368 $49.39 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 17, 2023, with the remaining RSUs vesting in 3 equal annual installments thereafter.
F2 25% of the option shares vest and become exercisable on May 17, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney